Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study

Jesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, Francisco Gómez-Veiga, Joan Bestard, Antonio Gómez-Caamaño, Anne-Sophie Grandoulier, Maria Pérez-Sampietro, Venancio Chantada-Abal, Raúl Poza de Celis, on behalf of ANAREN Study Group

Article Type

Original Research

Published

This study aims to determine the percentage of patients whose initial luteinizing hormone-releasing hormone agonists prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.

Read more

Topical treatment of radiation-induced dermatitis: current issues and potential solutions

Nicola Alessandro Iacovelli MD, Yvan Torrente MD, PhD, Adriana Ciuffreda MD, Vittorio A Guardamagna MD, PhD, Marta Gentili MS, Luca Giacomelli PhD, Paola Sacerdote PhD

Article Type

Review

Published

The aim of this paper is to discuss current knowledge on radiation-induced dermatitis and propose targets for the prevention/treatment of this
condition. On these bases, the characteristics of the ‘ideal’
compound to address this side effect will be described.

Read more

Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents

Gabriela Antelo MD, Cinta Hierro MD, MSc, Juan Pablo Fernández MD, Eduardo Baena MD, Cristina Bugés MD, Laura Layos MD, José Luis Manzano MD, Mónica Caro MD, Ricard Mesia MD, PhD

Article Type

Review

Published

This article discusses the current management of this rare entity and provide an overview of the most relevant molecular findings, whilst illustrating the potential value that prescreening panels can offer, searching for actionable targets (MSI/dMMR, PD-L1, BRAFv600E) to guide therapy with promising agents that could fill a void in this disease.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.